Results 291 to 300 of about 413,499 (385)

Autophagy in High-Fat Diet and Streptozotocin-Induced Metabolic Cardiomyopathy: Mechanisms and Therapeutic Implications. [PDF]

Int J Mol Sci
Zhou R, Zhang Z, Li X, Duan Q, Miao Y, Zhang T, Wang M, Li J, Zhang W, Wang L, Jones OD, Xu M, Liu Y, Xu X.   +13 more
europepmc   +1 more source

Cardiopulmonary exercise testing as a prognosis‐assessing tool in heart failure with preserved ejection fraction

ESC Heart Failure, EarlyView.
Abstract Aims Patients with heart failure with preserved ejection fraction represent half of the heart failure patients nowadays, an at least steady trend due to the aging of the population. We investigated whether the parameters obtained from cardiopulmonary exercise testing (CPET) correlated with the prognosis of these patients.
C. Rozados da Conceicao, A. Krannich, V. Zach, R. Pinto, A. Deichl, A. Feuerstein, L. Schleussner, F. Edelmann   +7 more
wiley   +1 more source

Rapid progression of right ventricular dysfunction: a case report. [PDF]

BMC Cardiovasc Disord
Li G, Zhao C, Wu L, Yan Y.
europepmc   +1 more source

Prognostic impact of gait speed, muscle strength and muscle mass in chronic heart failure—A prospective cohort study

ESC Heart Failure, EarlyView.
The prognostic impact of the muscle parameters gait speed, handgrip strength and appendicular skeletal muscle index on cardiovascular outcomes was investigated. We prospectively analyzed a cohort of 205 heart failure patients with a median left ventricular ejection fraction of 37% and a median follow‐up of 4.7 years.
Vladimir Cejka, Hermann Riepl, Nora Schwegel, Ewald Kolesnik, David Zach, Viktoria Santner, Viktoria Höller, Natascha Schweighofer, Barbara Obermayer‐Pietsch, Thomas Pieber, Caroline Morbach, Stefan Frantz, Andreas Zirlik, Dirk von Lewinski, Stefan Störk, Florian Posch, Klemens Ablasser, Nicolas Verheyen   +17 more
wiley   +1 more source

An Unusual Case of 11αB-Crystallin (CRYAB) Mutation as a Cause of Dilated Cardiomyopathy With Restrictive Physiology: A Case Report and Focused Review of the Literature. [PDF]

Clin Case Rep
Cristian Orlando PB, Roberto Hernando CB, Alejandro MC, Edward Andres CM, Meek E, Edgar Giovanni RD.   +5 more
europepmc   +1 more source

Natural Course of Cardiomyopathy in Duchenne Muscular Dystrophy : SYMPOSIUM ON SECONDARY MYOCARDIAL DISEASE : 44th Scientific Session of the Japanise Circulation Society

, 1979
Hiromitsu Tanaka, Seiji Nishi, H. Katanasako   +2 more
openalex   +2 more sources

Cardiac myosin binding protein C correlate with cardiac troponin I during an exercise training program in patients with HFrEF

ESC Heart Failure, EarlyView.
Abstract Background Cardiac myosin binding protein C (cMyC) is an emerging new biomarker of myocardial injury rising earlier and cleared faster than cardiac troponins. It has discriminatory power similar to high‐sensitive troponins in diagnosing myocardial infarction in patients presenting with chest pain. It is also associated with outcome in patients
E. Riveland, A. Ushakova, T. Valborgland, T. Karlsen, H. Dalen, E. Prescott, T. Omland, A. Linke, M. Halle, M. Marber, Ø. Ellingsen, A.I. Larsen, on behalf of the SMARTEX‐HF Study Group   +12 more
wiley   +1 more source

Idiopathic Cardiomyopathy

, 1978
T Takatsu
openalex   +2 more sources

SGLT2i reduce arrhythmic events in heart failure patients with cardiac implantable electronic devices

ESC Heart Failure, EarlyView.
Abstract Background Sodium glucose cotransporter 2 inhibitors (SGLT2i) represent one of the four pillars of heart failure (HF) pharmacological therapy. Objective The study aims to clarify SGLT2i antiarrhythmic effect on patients with HF with reduced ejection fraction (HFrEF) in terms of atrial and ventricular arrhythmias (AAs and VAs) reduction ...
Marco Valerio Mariani, Carlo Lavalle, Marta Palombi, Nicola Pierucci, Sara Trivigno, Andrea D'Amato, Domenico Filomena, Pietro Cipollone, Domenico Laviola, Agostino Piro, Silvia Prosperi, Josefina Magliolo, Vincenzo Myftari, Vincenzo Mirco La Fazia, Paolo Severino, Cristina Chimenti, Roberto Badagliacca, Carmine Dario Vizza   +17 more
wiley   +1 more source

Mavacamten maintenance dose determination: insights into individualised therapy for hypertrophic cardiomyopathy. [PDF]

Open Heart
Scholtz S, Coppée C, Mohemed K, Potratz M, Sequeira V, Rudolph V, Scholtz W, Reil JC.   +7 more
europepmc   +1 more source